Breckenridge Pharmaceutical Signs Letter Of Intent For Long Term Agreement With Orit Laboratories

pharmiweb.co.uk     Apr 12, 2008            

Pharmaceutical Online ... Breckenridge announced recently that it has entered into an agreement with Orit Laboratories to market 2 separate generic ANDA products. The first project is currently filed and pending FDA approval. The companies plan to file an ANDA with the... [read full story]                    

Full Coverage

Breckenridge Pharmaceutical Signs Letter of Intent for Long Term Agreement With Orit Laboratories...

prnewswire.com     Apr 10, 2008          

Breckenridge Pharmaceutical Signs Letter of Intent for Long Term Agreement With Orit Laboratories (West Caldwell, NJ) BOCA RATON, Fla., April 10 /PRNewswire/ -- Breckenridge announced today that it has entered into an agreement with Orit Laboratories to market 2 separate...                    

comments

Breckenridge signs letter of intent with Orit

pharmaceutical-business-review.com     Apr 12, 2008          

Breckenridge has entered into an agreement with Orit Laboratories to market two separate generic abbreviated new drug application products. ... The first project is currently filed and pending FDA approval. The companies plan to file an abbreviated new drug application...                    

comments